University of Dundee

School of Research

Short Code: 

Virtual Summer School is a success in Life Sciences

During the SLS summer school students usually expect to gain wet lab experience and benefit from working alongside PhD students and postdoctoral researchers on the bench. The coronavirus pandemic has had a major impact on this year’s programme as access to the labs was restricted and placements cancelled. Instead, twenty Dundee undergraduates from second and third year undertook virtual projects over a period of five weeks.

COVID Stories: Drug Discovery Unit led contributions to worldwide effort to tackle coronaviruses (Part 3)

Since the end of June, our researchers have been returning to the School of Life Sciences to restart their lab-based research. This work encompasses a diverse range of topics from microbiology to gene regulation and plant sciences to drug discovery. Alongside this, scientists are continuing to contribute to the worldwide efforts to tackle COVID-19. Some projects are progressing while others are just starting up following recent funding awards. What is it like as a scientist working with social distancing and additional measures in place in the research laboratories?

Scottish universities at forefront of €78 million anti-Covid effort

  • CARE (Corona Accelerated R&D in Europe) is the largest undertaking of its kind dedicated to discovering and developing urgently needed treatment options for Covid-19
  • The initiative is committed to a long-term understanding of the disease and development of therapies for Covid-19 and future coronavirus threats in addition to urgent efforts to repurpose existing therapies for a potential immediate response

£7.5 million to accelerate drug discovery process

Three of the world’s leading pharmaceutical companies have pledged £7.5 million to allow the University of Dundee’s Division of Signal Transduction Therapy (DSTT) to continue its award-winning work.

Pharmaceutical giants Boehringer Ingelheim, GlaxoSmithKline and Merck KGaA, Darmstadt, Germany, will provide the multi-million pound support for fundamental research in multiple therapeutic areas, including cancer, arthritis, lupus, hypertension and Parkinson’s disease. This new round of funding will support dozens of posts at Dundee for the next four years.